DHCR24 encodes Delta(24)-sterol reductase (also known as seladin-1), the terminal enzyme in cholesterol biosynthesis that catalyzes the reduction of the delta-24 double bond of sterol intermediates, primarily converting desmosterol to cholesterol. The enzyme is FAD-dependent, requires NADPH as a cofactor, and is localized to the endoplasmic reticulum membrane. DHCR24 also confers neuroprotection against oxidative stress and amyloid-beta toxicity. Mutations in DHCR24 cause desmosterolosis, a rare autosomal recessive disorder of cholesterol biosynthesis characterized by multiple congenital anomalies and elevated desmosterol levels.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
REMOVE |
Summary: IBA annotation for cytoplasm is incorrect. DHCR24 is an integral ER membrane protein with its catalytic domain oriented toward the cytoplasm [PMID:11007892, PMID:22010141]. The cytoplasmic annotation reflects the cytoplasmic orientation of the catalytic domain rather than true cytoplasmic localization.
Reason: This annotation incorrectly implies cytoplasmic localization when the protein is actually an integral ER membrane protein with a cytoplasmic-facing catalytic domain. The UniProt record and experimental evidence clearly establish ER membrane as the primary localization [PMID:11007892, PMID:22010141].
Supporting Evidence:
PMID:22010141
We showed that full-length DHCR24 is localized to the membrane of ER, whereas the predicted transmembrane (TM) domain-deleted DHCR24 mutation is localized to the cytoplasm. The change of DHCR24 localization suggests that the N-terminal TM domain is essential for the ER membrane targeting of DHCR24.
|
|
GO:0008202
steroid metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for steroid metabolic process is accurate. DHCR24 is a key enzyme in cholesterol biosynthesis, which is part of steroid metabolism. The annotation is at an appropriate level of specificity given that cholesterol is the precursor for all steroid hormones.
Reason: DHCR24 clearly participates in steroid metabolism through its essential role in cholesterol biosynthesis. Cholesterol is both a steroid itself and the precursor for all steroid hormones. The IBA annotation is well-supported by experimental evidence [PMID:11519011].
Supporting Evidence:
PMID:11519011
We identified the human DHCR24 cDNA, by the similarity between the encoded protein and a recently characterized plant enzyme—DWF1/DIM, from Arabidopsis thaliana —catalyzing a different but partially similar reaction in steroid/sterol biosynthesis in plants. Heterologous expression, in the yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that it encodes DHCR24
|
|
GO:0000246
Delta24(24-1) sterol reductase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for Delta24(24-1) sterol reductase activity is correct and represents a core molecular function. This term specifically describes the enzymatic activity of DHCR24 in reducing the delta-24 double bond in sterols, which is directly validated by experimental evidence [PMID:11519011].
Reason: This is the core molecular function of DHCR24, experimentally validated through multiple studies. The enzyme specifically catalyzes the reduction of the delta-24 double bond in sterol intermediates, including desmosterol, lanosterol, and zymosterol [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate and is increased twofold by the addition of FAD to the assay
|
|
GO:0050614
Delta24-sterol reductase activity
|
IEA
GO_REF:0000003 |
ACCEPT |
Summary: IEA annotation for Delta24-sterol reductase activity based on EC number mapping. This is essentially the same function as GO:0000246 but with slightly different terminology. Both terms correctly describe the core enzymatic function of DHCR24.
Reason: This annotation accurately describes the enzymatic activity of DHCR24. The term is based on EC:1.3.1.72 mapping which is experimentally validated [PMID:11519011]. This is a duplicate of GO:0000246 with different terminology but both are correct.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0000139
Golgi membrane
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: IEA annotation for Golgi membrane based on UniProt subcellular location vocabulary. DHCR24 is detected in Golgi to a lesser extent than ER, where cholesterol synthesis occurs [PMID:11007892].
Reason: Golgi localization occurs to a minor extent and is not the primary functionally relevant site. The ER membrane is the established primary location for DHCR24 function in cholesterol biosynthesis. UniProt notes both localizations but emphasizes ER [PMID:11007892].
Supporting Evidence:
PMID:11007892
subcellular fractionation and enzyme assays... seladin-1 is predominantly localized within the ER, and to a lesser amount in Golgi complexes
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: IEA annotation for endoplasmic reticulum membrane is accurate and represents the primary cellular localization. This is the established site where DHCR24 performs its enzymatic function in cholesterol biosynthesis, confirmed by multiple experimental studies [PMID:11007892, PMID:22010141].
Reason: ER membrane is the correct and primary localization for DHCR24. This is where the enzyme performs its function in cholesterol biosynthesis. Multiple experimental studies confirm this localization [PMID:11007892, PMID:22010141].
Supporting Evidence:
PMID:11007892
seladin-1 is predominantly localized within the ER, and to a lesser amount in Golgi complexes
|
|
GO:0006629
lipid metabolic process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation for lipid metabolic process based on UniProt keyword mapping. This is accurate but very general. More specific terms like cholesterol biosynthetic process (GO:0006695) better describe the function.
Reason: While accurate, this is a very broad parent term. DHCR24 does participate in lipid metabolism through its role in cholesterol biosynthesis. However, more specific child terms provide better functional description.
Supporting Evidence:
PMID:11519011
in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0006694
steroid biosynthetic process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation for steroid biosynthetic process is accurate. DHCR24 is essential for cholesterol biosynthesis, and cholesterol is both a steroid and the precursor for all steroid hormones.
Reason: DHCR24 directly participates in steroid biosynthesis through its essential role in producing cholesterol, which is a steroid molecule and the precursor for all steroid hormones [PMID:11519011].
Supporting Evidence:
PMID:11519011
desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
|
|
GO:0006695
cholesterol biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for cholesterol biosynthetic process is accurate and represents a core function. DHCR24 is the terminal enzyme in cholesterol biosynthesis, converting desmosterol to cholesterol [PMID:11519011].
Reason: This is a core biological process for DHCR24. The enzyme catalyzes the final step in cholesterol biosynthesis, converting desmosterol to cholesterol. This is experimentally validated [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
|
|
GO:0008202
steroid metabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Duplicate IEA annotation for steroid metabolic process (also annotated with IBA evidence). The annotation is accurate as DHCR24 participates in cholesterol/steroid metabolism.
Reason: Duplicate but accurate annotation. DHCR24 participates in steroid metabolism through cholesterol biosynthesis. The IBA version of this annotation was already accepted.
Supporting Evidence:
PMID:11519011
cholesterol-biosynthesis disorder caused by mutations in DHCR24
|
|
GO:0008203
cholesterol metabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for cholesterol metabolic process is accurate. DHCR24 is directly involved in cholesterol metabolism as the terminal enzyme in cholesterol biosynthesis.
Reason: DHCR24 is a key enzyme in cholesterol metabolism, specifically in the biosynthetic pathway. The annotation accurately captures this core function [PMID:11519011].
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0016126
sterol biosynthetic process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation for sterol biosynthetic process is accurate. DHCR24 is essential for sterol biosynthesis, specifically in the final step of converting sterol intermediates to cholesterol.
Reason: DHCR24 is a key enzyme in sterol biosynthesis, catalyzing the reduction of the delta-24 double bond in various sterol intermediates including desmosterol, lanosterol, and zymosterol [PMID:11519011].
Supporting Evidence:
PMID:11519011
catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0016491
oxidoreductase activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: IEA annotation for oxidoreductase activity is accurate but very general. DHCR24 is indeed an oxidoreductase, specifically a FAD-dependent oxidoreductase that uses NADPH. More specific terms like GO:0016628 provide better functional description.
Reason: DHCR24 is a FAD-dependent oxidoreductase that catalyzes redox reactions using NADPH as electron donor. While accurate, more specific child terms better describe the function [PMID:11519011].
Supporting Evidence:
PMID:11519011
member of a recently defined family of flavin adenine dinucleotide (FAD)-dependent oxidoreductases
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation for FAD binding based on InterPro domain mapping. This is accurate as DHCR24 contains a FAD-binding domain and FAD enhances its enzymatic activity [PMID:11519011].
Reason: DHCR24 is a FAD-dependent oxidoreductase with a conserved FAD-binding domain. Addition of FAD increases enzymatic activity twofold, suggesting noncovalent FAD binding [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate and is increased twofold by the addition of FAD to the assay
|
|
GO:0071949
FAD binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Duplicate IEA annotation for FAD binding (same as GO:0050660). The annotation is accurate as DHCR24 is a FAD-dependent enzyme.
Reason: Duplicate of GO:0050660 but accurate. DHCR24 requires FAD as a cofactor for its oxidoreductase activity [PMID:11519011].
Supporting Evidence:
PMID:11519011
member of a recently defined family of flavin adenine dinucleotide (FAD)-dependent oxidoreductases
|
|
GO:0005515
protein binding
|
IPI
PMID:30021884 Histone Interaction Landscapes Visualized by Crosslinking Ma... |
REMOVE |
Summary: Generic protein binding annotation from a large-scale crosslinking mass spectrometry study of intact cell nuclei [PMID:30021884]. The WITH field indicates interaction with PGRMC1 (O00264). The DHCR24-PGRMC1 interaction was detected by crosslinking mass spectrometry (both are ER membrane proteins involved in sterol biology), but the generic protein binding term is uninformative.
Reason: Protein binding without specificity is uninformative per curation guidelines. The interaction was detected in a high-throughput crosslinking study and the functional significance of the DHCR24-PGRMC1 interaction is not well characterized.
Supporting Evidence:
PMID:30021884
Here we use crosslinking mass spectrometry (XL-MS) to chart the protein-protein interactions in intact human nuclei.
|
|
GO:0005515
protein binding
|
IPI
PMID:35271311 OpenCell: Endogenous tagging for the cartography of human ce... |
REMOVE |
Summary: Generic protein binding annotation from OpenCell high-throughput endogenous tagging study [PMID:35271311]. The WITH field indicates interaction with PGRMC1 (O00264). While PGRMC1 is a known sterol-binding ER membrane protein, the generic protein binding term is uninformative per curation guidelines.
Reason: Non-specific protein binding annotation from high-throughput study lacks functional context. The curation guidelines explicitly state to avoid this vague term. A more specific MF term should be used if the interaction is validated.
Supporting Evidence:
PMID:35271311
We combined genome engineering, confocal live-cell imaging, mass spectrometry, and data science to systematically map the localization and interactions of human proteins.
|
|
GO:0006695
cholesterol biosynthetic process
|
TAS
Reactome:R-HSA-191273 |
ACCEPT |
Summary: TAS annotation from Reactome for cholesterol biosynthetic process. This is a core function of DHCR24 as the terminal enzyme in cholesterol biosynthesis.
Reason: DHCR24 is the terminal enzyme in cholesterol biosynthesis. This Reactome annotation accurately captures this core biological process [PMID:11519011].
Supporting Evidence:
PMID:11519011
desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
|
|
GO:0033489
cholesterol biosynthetic process via desmosterol
|
TAS
Reactome:R-HSA-6807047 |
ACCEPT |
Summary: TAS annotation from Reactome for cholesterol biosynthesis via desmosterol. This is the primary pathway where DHCR24 functions, converting desmosterol to cholesterol in the Bloch pathway.
Reason: This specifically describes the Bloch pathway where DHCR24 catalyzes the conversion of desmosterol to cholesterol. This is the primary route and core function of DHCR24 [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
|
|
GO:0033490
cholesterol biosynthetic process via lathosterol
|
TAS
Reactome:R-HSA-6807062 |
ACCEPT |
Summary: TAS annotation from Reactome for cholesterol biosynthesis via lathosterol (Kandutsch-Russell pathway). DHCR24 can act on various sterol intermediates including those in this alternate pathway.
Reason: DHCR24 functions in both the Bloch and Kandutsch-Russell pathways of cholesterol biosynthesis. It can reduce the delta-24 double bond in various sterol intermediates [PMID:25637936].
Supporting Evidence:
PMID:25637936
DHCR24 is positioned not only at the end of the Bloch pathway but also at the gateway of the Kandutsch-Russell pathway... able to act on any of the intermediates in the Bloch pathway to divert them into the Kandutsch-Russell pathway
|
|
GO:0007265
Ras protein signal transduction
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation for Ras signaling transferred from orthologs. While DHCR24/seladin-1 mediates response to Ras-induced senescence [PMID:15577914], this is a stress response function rather than core Ras signaling.
Reason: DHCR24/seladin-1 responds to oncogenic Ras stress but is not a core component of Ras signaling. It mediates Ras-induced senescence through p53 interactions [PMID:15577914]. This is a secondary, non-core function.
Supporting Evidence:
PMID:15577914
Seladin-1 (also known as Dhcr24) as a key mediator of Ras-induced senescence. Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus
|
|
GO:0008104
intracellular protein localization
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: IEA annotation for intracellular protein localization from ortholog transfer. This is vague and lacks supporting evidence for DHCR24 having a role in localizing other proteins.
Reason: No evidence that DHCR24 functions in protein localization. This appears to be an over-annotation from ortholog transfer without validation. The primary function is enzymatic in cholesterol biosynthesis.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0008285
negative regulation of cell population proliferation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation for negative regulation of proliferation. DHCR24/seladin-1 does mediate Ras-induced senescence and suppresses transformation [PMID:15577914], supporting an anti-proliferative role.
Reason: DHCR24/seladin-1 mediates oncogenic stress-induced senescence and suppresses cellular transformation [PMID:15577914]. This is a validated but non-core function distinct from its primary enzymatic role.
Supporting Evidence:
PMID:15577914
Ablation of Seladin-1 causes the bypass of Ras-induced senescence in rodent and human fibroblasts, and allows Ras to transform these cells
|
|
GO:0009725
response to hormone
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: IEA annotation for response to hormone from ortholog transfer. This is too vague without specifying which hormones. Cholesterol biosynthesis is regulated by hormones but this annotation lacks specificity.
Reason: Overly broad annotation without supporting evidence for specific hormone responses by DHCR24. While cholesterol biosynthesis is hormonally regulated, this vague annotation provides no functional insight.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0009888
tissue development
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation for tissue development from ortholog transfer. While DHCR24 mutations cause developmental anomalies in desmosterolosis, this is an indirect effect of cholesterol deficiency.
Reason: DHCR24 deficiency causes developmental defects in desmosterolosis patients [PMID:11519011], but this is secondary to cholesterol deficiency rather than a direct developmental role. Non-core but valid consequence.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
|
|
GO:0016125
sterol metabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation for sterol metabolic process is accurate. DHCR24 is directly involved in sterol metabolism through its enzymatic activity on various sterol intermediates.
Reason: DHCR24 directly participates in sterol metabolism by catalyzing the reduction of the delta-24 double bond in multiple sterol intermediates [PMID:11519011].
Supporting Evidence:
PMID:11519011
catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0030539
male genitalia development
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: IEA annotation for male genitalia development from ortholog transfer. While desmosterolosis can include urogenital anomalies, this is too specific and indirect.
Reason: Over-specific developmental annotation. While desmosterolosis includes congenital anomalies, singling out male genitalia development is not supported as a specific function of DHCR24. This is an indirect effect of cholesterol deficiency.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
|
|
GO:0031639
plasminogen activation
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: IEA annotation for plasminogen activation from ortholog transfer. No evidence supports DHCR24 involvement in plasminogen activation. This is an erroneous transfer.
Reason: No evidence linking DHCR24 to plasminogen activation. This is an incorrect ortholog transfer. DHCR24 functions in cholesterol biosynthesis, not coagulation/fibrinolysis pathways.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0042987
amyloid precursor protein catabolic process
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: IEA annotation for APP catabolism from ortholog transfer. While DHCR24/seladin-1 protects against amyloid-beta toxicity [PMID:11007892], it does not directly catabolize APP.
Reason: DHCR24/seladin-1 protects against amyloid-beta toxicity but does not catabolize APP. The protective effect is through reducing oxidative stress and caspase activation, not APP processing [PMID:11007892].
Supporting Evidence:
PMID:11007892
Functional expression of seladin-1 in human neuroglioma H4 cells resulted in the inhibition of caspase 3 activation after either Aβ-mediated toxicity or oxidative stress and protected the cells from apoptotic cell death
|
|
GO:0043588
skin development
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation for skin development from ortholog transfer. While cholesterol is important for skin barrier function, this is an indirect effect of DHCR24 enzymatic activity.
Reason: Cholesterol biosynthesis is important for skin development and barrier function. DHCR24 deficiency can affect skin, but this is secondary to its enzymatic role. Non-core but valid indirect function.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
|
|
GO:0061024
membrane organization
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: IEA annotation for membrane organization from ortholog transfer. While cholesterol is crucial for membrane structure, DHCR24 does not directly organize membranes.
Reason: DHCR24 produces cholesterol which affects membrane properties, but the enzyme itself does not organize membranes. This is an over-interpretation of its indirect effects through cholesterol production.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
|
|
GO:0050614
Delta24-sterol reductase activity
|
EXP
PMID:11519011 Mutations in the 3beta-hydroxysterol Delta24-reductase gene ... |
ACCEPT |
Summary: Experimental evidence for Delta24-sterol reductase activity from the key paper identifying DHCR24. This is the core molecular function, directly demonstrated through heterologous expression and enzyme activity measurements.
Reason: Direct experimental validation of DHCR24 enzymatic activity. The study used heterologous expression in yeast followed by enzyme activity measurements to confirm Delta24-sterol reductase activity [PMID:11519011].
Supporting Evidence:
PMID:11519011
Heterologous expression, in the yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that it encodes DHCR24
|
|
GO:0050614
Delta24-sterol reductase activity
|
TAS
Reactome:R-HSA-9755937 |
ACCEPT |
Summary: TAS annotation from Reactome for Delta24-sterol reductase activity, specifically for lanosterol reduction. This is a validated core molecular function of DHCR24.
Reason: DHCR24 catalyzes the reduction of the delta-24 double bond in multiple sterols including lanosterol. This Reactome annotation correctly captures this enzymatic activity [PMID:11519011].
Supporting Evidence:
file:human/DHCR24/DHCR24-uniprot.txt
Reaction=lanosterol + NADPH + H(+) = 24,25-dihydrolanosterol + NADP(+)
|
|
GO:0000246
Delta24(24-1) sterol reductase activity
|
IMP
PMID:11519011 Mutations in the 3beta-hydroxysterol Delta24-reductase gene ... |
ACCEPT |
Summary: IMP evidence for Delta24(24-1) sterol reductase activity from mutant phenotype analysis. Mutations in DHCR24 cause desmosterolosis with accumulation of desmosterol, proving this enzymatic function.
Reason: Mutations in DHCR24 cause desmosterolosis with elevated desmosterol levels, directly demonstrating the enzyme's Delta24-sterol reductase activity through mutant phenotype [PMID:11519011].
Supporting Evidence:
PMID:11519011
Patients with desmosterolosis have elevated levels of the cholesterol precursor desmosterol, in plasma, tissue, and cultured cells; this abnormality suggests a deficiency of the enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24)
|
|
GO:0005789
endoplasmic reticulum membrane
|
NAS
PMID:11007892 The human DIMINUTO/DWARF1 homolog seladin-1 confers resistan... |
ACCEPT |
Summary: NAS evidence for ER membrane localization from the seladin-1 paper. Subcellular fractionation confirmed predominant ER localization. This is the primary and functionally relevant cellular location.
Reason: Experimental subcellular fractionation demonstrated that seladin-1/DHCR24 is predominantly localized to the ER membrane, where it performs its enzymatic function [PMID:11007892].
Supporting Evidence:
PMID:11007892
subcellular fractionation and enzyme assays... seladin-1 is predominantly localized within the ER, and to a lesser amount in Golgi complexes
|
|
GO:0006695
cholesterol biosynthetic process
|
IMP
PMID:11519011 Mutations in the 3beta-hydroxysterol Delta24-reductase gene ... |
ACCEPT |
Summary: IMP evidence for cholesterol biosynthetic process from mutant phenotype. DHCR24 mutations cause desmosterolosis with defective cholesterol biosynthesis, proving this core function.
Reason: Mutations in DHCR24 cause desmosterolosis, a cholesterol biosynthesis disorder, directly demonstrating the enzyme's essential role in cholesterol biosynthesis [PMID:11519011].
Supporting Evidence:
PMID:11519011
Our data demonstrate that desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
|
|
GO:0033489
cholesterol biosynthetic process via desmosterol
|
IMP
PMID:11519011 Mutations in the 3beta-hydroxysterol Delta24-reductase gene ... |
ACCEPT |
Summary: IMP evidence for cholesterol biosynthesis via desmosterol pathway. Patients with DHCR24 mutations accumulate desmosterol, proving this is the enzyme that converts desmosterol to cholesterol.
Reason: DHCR24 deficiency causes desmosterol accumulation, directly demonstrating its role in the desmosterol-to-cholesterol conversion in the Bloch pathway [PMID:11519011].
Supporting Evidence:
PMID:11519011
Patients with desmosterolosis have elevated levels of the cholesterol precursor desmosterol... Conversion of desmosterol to cholesterol by DHCR24
|
|
GO:0005515
protein binding
|
IPI
PMID:25637936 The terminal enzymes of cholesterol synthesis, DHCR24 and DH... |
REMOVE |
Summary: IPI evidence for protein binding with DHCR7. While this specific DHCR7 interaction is functionally important, the generic "protein binding" term should be avoided per curation guidelines.
Reason: Generic protein binding annotation should be removed even for specific interactions. The functionally relevant DHCR7 interaction and its regulatory effect on enzyme activity is better captured by more specific functional terms.
Supporting Evidence:
PMID:25637936
when the DHCR24 gene is knocked down by siRNA, DHCR7 activity is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity, but only when a functional form of DHCR24 is used
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-196417 |
ACCEPT |
Summary: TAS annotation from Reactome for ER membrane localization. This is the correct primary localization where DHCR24 performs its enzymatic function.
Reason: ER membrane is the established localization for DHCR24 where it catalyzes the conversion of desmosterol to cholesterol [PMID:11007892, PMID:22010141].
Supporting Evidence:
PMID:22010141
The membrane topological analysis of 3β-hydroxysteroid-delta24 reductase (DHCR24) on endoplasmic reticulum
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-6807064 |
ACCEPT |
Summary: Another TAS annotation from Reactome for ER membrane. This is a duplicate but correct annotation for the primary cellular localization.
Reason: Duplicate but accurate ER membrane localization annotation from Reactome. Multiple evidence sources confirm this localization [PMID:11007892].
Supporting Evidence:
PMID:11007892
seladin-1 is predominantly localized within the ER
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9755937 |
ACCEPT |
Summary: Another TAS annotation from Reactome for ER membrane. Multiple Reactome pathways correctly place DHCR24 at the ER membrane.
Reason: Another duplicate but accurate ER membrane annotation. The ER is where DHCR24 performs its enzymatic function in cholesterol biosynthesis [PMID:11007892].
Supporting Evidence:
PMID:11007892
seladin-1 is predominantly localized within the ER
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
ACCEPT |
Summary: HDA evidence for membrane localization from NK cell proteomics study. This is very general compared to the specific ER membrane localization established by other studies.
Reason: While less specific than ER membrane annotations, this high-throughput data confirms DHCR24 is membrane-associated, consistent with its ER membrane localization [PMID:19946888].
Supporting Evidence:
PMID:19946888
Defining the membrane proteome of NK cells
|
|
GO:0016628
oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor
|
IDA
PMID:11519011 Mutations in the 3beta-hydroxysterol Delta24-reductase gene ... |
ACCEPT |
Summary: IDA evidence for specific oxidoreductase activity. This accurately describes DHCR24 mechanism - it reduces C-C double bonds (delta-24) using NADPH as electron donor.
Reason: Direct experimental demonstration that DHCR24 is an oxidoreductase acting on CH-CH groups (the delta-24 double bond) with NADPH as acceptor. This is more specific than general oxidoreductase activity [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
|
|
GO:0006695
cholesterol biosynthetic process
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for cholesterol biosynthetic process based on sequence similarity. This is a duplicate annotation but correctly identifies a core function.
Reason: Sequence similarity-based annotation that correctly identifies DHCR24 role in cholesterol biosynthesis. This is validated by experimental evidence [PMID:11519011].
Supporting Evidence:
PMID:11519011
desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
|
|
GO:0019899
enzyme binding
|
IPI
PMID:15577914 Regulation of cellular response to oncogenic and oxidative s... |
KEEP AS NON CORE |
Summary: IPI evidence for enzyme binding from the seladin-1 stress response paper. DHCR24/seladin-1 binds to Mdm2 (an E3 ubiquitin ligase) to regulate p53. This is a non-core stress response function.
Reason: DHCR24/seladin-1 binds the E3 ubiquitin ligase Mdm2 during stress response, affecting p53 regulation. This is a validated but non-core function distinct from its primary enzymatic role [PMID:15577914].
Supporting Evidence:
PMID:15577914
Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53... Additionally, Seladin-1 associates with Mdm2 independently of p53
|
|
GO:0043588
skin development
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for skin development based on sequence similarity. While cholesterol is important for skin, this is an indirect effect of DHCR24 enzymatic function.
Reason: Cholesterol biosynthesis impacts skin development and barrier function. DHCR24 deficiency can cause skin abnormalities, but this is secondary to its enzymatic role. Non-core indirect function.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
|
|
GO:0005634
nucleus
|
IDA
PMID:15577914 Regulation of cellular response to oncogenic and oxidative s... |
KEEP AS NON CORE |
Summary: IDA evidence for nuclear localization from stress response study. DHCR24/seladin-1 translocates to the nucleus during oncogenic and oxidative stress [PMID:15577914], though the primary functional localization is ER membrane.
Reason: DHCR24/seladin-1 can localize to nucleus during stress response to interact with p53/Mdm2, but this is not the primary localization. Main function occurs at ER membrane [PMID:15577914, PMID:11007892].
Supporting Evidence:
PMID:15577914
Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53
|
|
GO:0005783
endoplasmic reticulum
|
IDA
PMID:11007892 The human DIMINUTO/DWARF1 homolog seladin-1 confers resistan... |
ACCEPT |
Summary: IDA evidence for ER localization from the seladin-1 paper. This is the correct primary localization, though ER membrane (GO:0005789) is more specific.
Reason: Direct experimental evidence for ER localization through subcellular fractionation. The more specific ER membrane term is also annotated [PMID:11007892].
Supporting Evidence:
PMID:11007892
subcellular fractionation and enzyme assays... seladin-1 is predominantly localized within the ER
|
|
GO:0009888
tissue development
|
IMP
PMID:12457401 Desmosterolosis presenting with multiple congenital anomalie... |
KEEP AS NON CORE |
Summary: IMP evidence for tissue development from a desmosterolosis case report showing developmental delay and anomalies. This is an indirect effect of cholesterol deficiency rather than a direct developmental role.
Reason: DHCR24 deficiency causes developmental anomalies in desmosterolosis due to cholesterol deficiency. This is an indirect consequence rather than a direct developmental function [PMID:12457401].
Supporting Evidence:
PMID:12457401
Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay
|
|
GO:0042605
peptide antigen binding
|
IPI
PMID:15577914 Regulation of cellular response to oncogenic and oxidative s... |
REMOVE |
Summary: IPI evidence for peptide antigen binding from the seladin-1 stress response study [PMID:15577914]. The WITH field shows UniProtKB:P04637 (p53), indicating the annotation was made based on seladin-1 binding the p53 N-terminus. However, this interaction is protein-protein binding to p53 during stress response, not peptide antigen binding in an immunological sense. The GO term peptide antigen binding (GO:0042605) refers to binding of antigenic peptides for immune presentation, which does not describe the DHCR24-p53 interaction.
Reason: This is a misannotation. PMID:15577914 describes DHCR24/seladin-1 binding to the p53 amino terminus during oncogenic and oxidative stress, displacing Mdm2. This is a protein-protein interaction, not peptide antigen binding in the immunological sense. No MHC or antigen presentation function is described.
Supporting Evidence:
PMID:15577914
Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53, thus resulting in p53 accumulation.
|
Q: How does DHCR24 coordinate cholesterol biosynthesis with membrane homeostasis and cellular sterol requirements?
Q: What are the regulatory mechanisms that control DHCR24 expression and activity in response to sterol levels?
Q: How do mutations in DHCR24 lead to desmosterolosis and what are the developmental consequences of altered sterol metabolism?
Q: What determines the subcellular localization of DHCR24 and how does this affect its function in sterol metabolism?
Experiment: Lipidomics analysis to characterize the complete sterol profile in DHCR24-deficient cells and tissues
Experiment: Live-cell imaging using fluorescent sterol analogs to track cholesterol metabolism and membrane distribution in real-time
Experiment: Cryo-EM structure determination of DHCR24 to understand the molecular basis of sterol reduction and enzyme specificity
Experiment: Developmental analysis of DHCR24 mutant model organisms to study the role of cholesterol in embryogenesis and organogenesis
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target is human DHCR24 (UniProt Q15392), encoding Δ(24)-sterol reductase (also called 24-dehydrocholesterol reductase, 3β-hydroxysterol Δ24-reductase, and seladin-1). This identity is consistent across recent reviews and primary studies, including work that explicitly retrieved the sequence from UniProt Q15392 for modeling/inhibitor screening. (fu2024dhcr24intumor pages 1-2, wang2023virtualscreeningof pages 12-13)
| Category | Key points | Evidence |
|---|---|---|
| Identity and synonyms | Human delta(24)-sterol reductase; gene DHCR24; also known as seladin-1; UniProt Q15392 | (fu2024dhcr24intumor pages 12-13, fu2024dhcr24intumor pages 1-2) |
| Enzymatic reaction and substrates | FAD-dependent reduction of the Δ24(25) double bond in sterol intermediates; converts desmosterol to cholesterol (terminal Bloch step) | (wang2023virtualscreeningof pages 1-2, bai2022theroleof pages 3-5) |
| Required cofactors/electron donor | Flavin adenine dinucleotide (FAD) cofactor; in vitro conversion strictly dependent on reduced NADPH; activity increased by added FAD | (cocciadiferro2024exploitinginsilico pages 1-2, wang2023virtualscreeningof pages 1-2) |
| Pathway placement | Operates in the Bloch pathway (desmosterol → cholesterol) and links to the Kandutsch–Russell route; controls post-lanosterol flux | (bai2022theroleof pages 3-5, skubic2024knockoutsofcyp51a1 pages 8-10) |
| Subcellular localization/topology | ER/Golgi-associated single-pass membrane enzyme; N-terminus luminal; C-terminal cytosolic region harbors FAD-binding domain | (fu2024dhcr24intumor pages 1-2, fu2024dhcr24intumor pages 12-13) |
| Notable inhibitors/regulators (quantitative) | Irbesartan is a competitive DHCR24 inhibitor (IC50 ≈ 602 nM in vitro); SH-42 reported as potent probe inhibitor (IC50 ≈ 4 nM); U18666A inhibits DHCR24 | (wang2023virtualscreeningof pages 1-2, peeples2024chemicalinhibitionof pages 17-18) |
| Genetic disease: desmosterolosis | Autosomal recessive sterol biosynthesis disorder with elevated desmosterol; neurodevelopmental anomalies; recent case validated novel p.M169T variant affecting FAD interactions | (cocciadiferro2024exploitinginsilico pages 1-2, fu2024dhcr24intumor pages 12-13) |
| 2023–2024 finding: AD model | AAV-mediated hippocampal DHCR24 overexpression in 5xFAD mice increased cholesterol and reversed cognitive impairment and AD-like pathology | (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15) |
| 2023–2024 finding: melanoma resistance | DHCR24/27HC axis promotes melanoma spheroid growth and vemurafenib resistance; 27-hydroxycholesterol increased by ~41.39% (from 89.784→129.240 ng/mL; p=0.0000751) upon DHCR24 overexpression | (wang2024cholesterolneutralizedvemurafenib pages 10-13, wang2024cholesterolneutralizedvemurafenib media 6e0d6af5) |
| 2023–2024 finding: diet-induced brain injury | High-fat diet downregulated DHCR24 protein in mouse brain, associated with neuronal apoptosis and ER-stress markers; DHCR24 overexpression rescued cholesterol-loading toxicity in N2a cells | (lu2023highfatdiet pages 9-12) |
Table: Compact functional-annotation table for human DHCR24 (Q15392), covering identity, reaction, cofactors, pathway position, localization, inhibitors, genetic disease, and recent 2023–2024 model findings with quantitative data. Each entry includes primary evidence citations for rapid reference.
DHCR24 is a flavin adenine dinucleotide (FAD)-dependent oxidoreductase in the distal cholesterol biosynthetic pathway that reduces the Δ24 double bond of sterol intermediates; in the canonical Bloch pathway it catalyzes desmosterol → cholesterol. (wang2023virtualscreeningof pages 1-2, bai2022theroleof pages 3-5)
Biochemical requirements include reduced NADPH (as electron donor) and FAD as cofactor; in vitro desmosterol→cholesterol conversion by DHCR24 is reported as strictly NADPH-dependent and ~2-fold increased by addition of FAD. (cocciadiferro2024exploitinginsilico pages 1-2)
DHCR24 is positioned at a late step of cholesterol synthesis and is described as acting on sterols in the Bloch arm, with sterol intermediates able to shift between Bloch and Kandutsch–Russell routes (post-lanosterol), making DHCR24 activity a key determinant of sterol intermediate pools (e.g., desmosterol accumulation upon loss/inhibition). (bai2022theroleof pages 3-5, fu2024dhcr24intumor pages 2-3)
DHCR24 is a membrane-associated enzyme localized to endoplasmic reticulum (ER) (and described in review sources as present in ER/Golgi-associated membranes), with a single-pass transmembrane segment and a largely cytosolic C-terminal region containing the FAD-binding domain and interaction regions (e.g., reported p53/Mdm2 binding regions in cancer-oriented reviews). (fu2024dhcr24intumor pages 1-2, fu2024dhcr24intumor pages 2-3)
| Year | Study (first author) | Publication (journal) | System/model | Key finding | Quantitative/statistical highlights | Potential application/implementation |
|---|---|---|---|---|---|---|
| 2023 | Wang | Molecules | HepG2 cells; high-fat-diet (HFD) mice | Repurposed DHCR24 inhibitors (incl. irbesartan) competitively inhibit DHCR24 and reduce cholesterol | Irbesartan IC50 = 602 nM in immune-complex assay; reduced cellular cholesterol and improved serum lipids in HFD mice (wang2023virtualscreeningof pages 1-2) | Cholesterol-lowering strategy; candidate repurposing for patients with hyperlipidemia and comorbidities (wang2023virtualscreeningof pages 1-2) |
| 2023 | Zhang | Acta Neuropathol Commun | 5xFAD Alzheimer’s mice; AAV-DHCR24 hippocampal delivery | DHCR24 overexpression raised hippocampal cholesterol and reversed cognitive deficits and AD-like pathology | Significant behavioral rescue; reduced amyloid-β; increased filipin cholesterol signal (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15) | Gene therapy approach to restore neuronal cholesterol in AD (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15) |
| 2023 | Lu | Cell Tissue Res | HFD mouse brain; N2a neuronal cells | HFD downregulated DHCR24 protein via ubiquitination (MDM2); DHCR24 overexpression rescued cholesterol-loading toxicity | ER-stress markers (BiP/CHOP) up; DHCR24 protein decreased despite mRNA unchanged; rescue by Ad-DHCR24 (lu2023highfatdiet pages 9-12) | Targeting MDM2/DHCR24 axis; neuroprotection under metabolic stress (lu2023highfatdiet pages 9-12) |
| 2024 | Wang | Cell Mol Life Sci | Melanoma (A375/A2058) spheroids; patient datasets | DHCR24-driven cholesterol elevates 27-hydroxycholesterol (27HC) to activate Rap1–PI3K/AKT and vemurafenib resistance | 27HC ↑41.39% (89.784 → 129.240 ng/mL; p=0.0000751) with DHCR24 overexpression; CYP27A1 inhibition (dafadine-A) attenuated resistance (wang2024cholesterolneutralizedvemurafenib pages 10-13, wang2024cholesterolneutralizedvemurafenib media 6e0d6af5) | Target CYP27A1/27HC to overcome BRAF inhibitor resistance (wang2024cholesterolneutralizedvemurafenib pages 10-13, wang2024cholesterolneutralizedvemurafenib media 6e0d6af5) |
| 2024 | Skubic | iScience | HepG2 DHCR24 knockout; sterolomics/transcriptomics | Desmosterol accumulation and sterol rewiring alter proliferation and WNT/LEF1 signaling | G0+G1 increased to 63% in DHCR24 KO vs 58% native; distinct pathway changes vs CYP51/SC5D KOs (skubic2024knockoutsofcyp51a1 pages 8-10, skubic2024knockoutsofcyp51a1 pages 10-12) | Pathway-informed targeting by sterol intermediates; cell-cycle modulation biomarkers (skubic2024knockoutsofcyp51a1 pages 8-10, skubic2024knockoutsofcyp51a1 pages 10-12) |
| 2024 | Cocciadiferro | Front Genet | Desmosterolosis patient (WES; MD sims; biochemical assay) | Novel DHCR24 variant p.M169T disrupts FAD interactions; genotype–phenotype expansion | In vitro desmosterol→cholesterol conversion strictly NADPH-dependent; +FAD doubles activity; variant validated deleterious (cocciadiferro2024exploitinginsilico pages 1-2) | Genetic diagnosis/variant interpretation; counseling and mechanistic insight (cocciadiferro2024exploitinginsilico pages 1-2) |
| 2024 | Peeples | Biomolecules (review) | Chemical inhibition landscape | Late-pathway druggability; SH42 probe; amiodarone and other FDA drugs can inhibit DHCR24; desmosterol links to LXR/pro-resolving mediators | SH42 highlighted as potent probe; catalog of inhibitors; translational/safety gaps noted (peeples2024chemicalinhibitionof pages 6-7, peeples2024chemicalinhibitionof pages 17-18) | Safety pharmacology; probe-led mechanistic and therapeutic development (peeples2024chemicalinhibitionof pages 6-7, peeples2024chemicalinhibitionof pages 17-18) |
Table: A concise table of 2023–2024 developments and applications for DHCR24, spanning biochemistry, disease models, genetics, and translational strategies. It includes quantitative metrics (e.g., IC50, 27HC change) and potential implementations, with inline citations to primary sources.
A 2024 study expanded DHCR24-related desmosterolosis by reporting a patient homozygous for DHCR24 p.M169T (c.506T>C) with functional validation and molecular dynamics evidence implicating disrupted interactions in/near the FAD/cofactor interaction network; this strengthens mechanistic interpretation of pathogenic alleles affecting the catalytic core. (cocciadiferro2024exploitinginsilico pages 1-2)
A 2023 inhibitor repurposing study identified multiple DrugBank candidates (irbesartan, risperidone, tolvaptan, conivaptan) that lowered cholesterol in HepG2 cells and improved lipid parameters in a mouse hyperlipidemia model; it quantified irbesartan inhibition of DHCR24 with IC50 = 602 nM using an in vitro enzymatic assay. (wang2023virtualscreeningof pages 1-2, wang2023virtualscreeningof pages 12-13)
A 2024 review emphasized the broader “chemical inhibition landscape” of post-lanosterol sterol synthesis and highlighted potent DHCR24 chemical probes (e.g., SH42) and the possibility that numerous FDA-approved medications can inhibit late sterol enzymes (including DHCR24), arguing that sterol pathway inhibition is underappreciated in safety contexts. (peeples2024chemicalinhibitionof pages 6-7, peeples2024chemicalinhibitionof pages 17-18)
A 2024 iScience study used HepG2 DHCR24 knockout (and other late-pathway KOs) to show that distinct sterol intermediate accumulation states drive distinct regulatory programs and cell-cycle phenotypes; in the DHCR24 KO, the G0+G1 fraction increased to 63% vs 58% in native cells, consistent with slower growth under some conditions and supporting the concept that distal intermediates (e.g., desmosterol) are not merely inert precursors. (skubic2024knockoutsofcyp51a1 pages 8-10)
Blocking DHCR24 is being investigated as a cholesterol-lowering approach. In a 2023 study, competitive DHCR24 inhibition by irbesartan was proposed as a repurposing strategy, supported by cell-based cholesterol lowering and an in vitro IC50 of 602 nM. (wang2023virtualscreeningof pages 1-2)
Real-world implementation remains preclinical for DHCR24-selective agents, but the concept intersects with pharmacovigilance: a 2024 review catalogued many chemical exposures and approved drugs that can inhibit post-lanosterol sterol biosynthesis, implying that off-target DHCR24 inhibition may already occur in clinical practice and could be relevant to safety (especially in pregnancy/neurodevelopment). (peeples2024chemicalinhibitionof pages 6-7)
In a 2023 Alzheimer’s mouse model study, hippocampal delivery of AAV-DHCR24 in 5xFAD mice increased filipin-detectable cholesterol in hippocampus and was reported to significantly reverse cognitive impairment and multiple AD-related pathological readouts (amyloid-β deposition, synaptic injury markers, glial activation, autophagy, apoptosis). This is a concrete preclinical implementation of DHCR24 modulation as a disease-modifying strategy. (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15)
A 2024 melanoma study reported that reducing intracellular cholesterol by DHCR24 knockdown impaired proliferation/migration and reduced xenograft tumor volume, while DHCR24/cholesterol promoted spheroid growth and vemurafenib resistance through a cholesterol-metabolite mechanism involving 27-hydroxycholesterol (27HC) and Rap1–PI3K/AKT signaling. (wang2024cholesterolneutralizedvemurafenib pages 1-2, wang2024cholesterolneutralizedvemurafenib pages 10-13)
A 2024 cancer-focused review frames DHCR24 as both a cholesterol-synthesis enzyme and a regulator intersecting with oncogenic signaling (e.g., ROS, p53, Ras, PI3K/AKT) and emphasizes DHCR24’s membrane topology/interaction regions when interpreting non-enzymatic phenotypes; although narrative, it consolidates evidence linking cholesterol pathway flux to tumor progression and therapy response. (fu2024dhcr24intumor pages 1-2, fu2024dhcr24intumor pages 12-13)
A 2024 sterol-inhibition review argues that late-pathway sterol inhibition (including DHCR24) is an underrecognized mechanism by which diverse chemicals and medications can perturb homeostasis, and it highlights knowledge gaps in both mechanisms and long-term consequences—an expert consensus-style warning relevant for translational work. (peeples2024chemicalinhibitionof pages 6-7)
DHCR24 (Q15392) is best annotated as an ER-associated, single-pass membrane FAD-dependent oxidoreductase that performs Δ24(25) sterol double-bond reduction in distal cholesterol biosynthesis, most classically converting desmosterol to cholesterol in the Bloch pathway. (fu2024dhcr24intumor pages 1-2, wang2023virtualscreeningof pages 1-2)
Because DHCR24 sits at a distal branchpoint that shapes sterol intermediate pools, its perturbation can produce pleiotropic effects via (i) cholesterol availability (membrane structure, lipid rafts), and (ii) bioactive intermediates such as desmosterol and oxysterols (e.g., 27HC), which can engage nuclear receptors and signaling pathways. This mechanistic framing is directly supported by recent cell and disease-model studies showing DHCR24-dependent shifts to 27HC with downstream Rap1–PI3K/AKT activation in melanoma, and by sterol-intermediate-driven transcriptional/cell-cycle remodeling in engineered KO systems. (wang2024cholesterolneutralizedvemurafenib pages 10-13, skubic2024knockoutsofcyp51a1 pages 8-10)
Quantitative 27HC changes upon DHCR24 overexpression are supported by a table and figure panels extracted from Wang et al. 2024 (Table 2; Fig. 3J–K). (wang2024cholesterolneutralizedvemurafenib media 6e0d6af5, wang2024cholesterolneutralizedvemurafenib media ab69483a)
References
(fu2024dhcr24intumor pages 1-2): Xin Fu and Zhaosong Wang. Dhcr24 in tumor diagnosis and treatment: a comprehensive review. Technology in Cancer Research & Treatment, Jan 2024. URL: https://doi.org/10.1177/15330338241259780, doi:10.1177/15330338241259780. This article has 17 citations and is from a peer-reviewed journal.
(wang2023virtualscreeningof pages 12-13): Haozhen Wang, Ziyin Lu, Yang Li, Ting Liu, Linlin Zhao, Tianqi Gao, Xiuli Lu, and Bing Gao. Virtual screening of novel 24-dehydroxysterol reductase (dhcr24) inhibitors and the biological evaluation of irbesartan in cholesterol-lowering effect. Molecules, 28:2643, Mar 2023. URL: https://doi.org/10.3390/molecules28062643, doi:10.3390/molecules28062643. This article has 15 citations.
(fu2024dhcr24intumor pages 12-13): Xin Fu and Zhaosong Wang. Dhcr24 in tumor diagnosis and treatment: a comprehensive review. Technology in Cancer Research & Treatment, Jan 2024. URL: https://doi.org/10.1177/15330338241259780, doi:10.1177/15330338241259780. This article has 17 citations and is from a peer-reviewed journal.
(wang2023virtualscreeningof pages 1-2): Haozhen Wang, Ziyin Lu, Yang Li, Ting Liu, Linlin Zhao, Tianqi Gao, Xiuli Lu, and Bing Gao. Virtual screening of novel 24-dehydroxysterol reductase (dhcr24) inhibitors and the biological evaluation of irbesartan in cholesterol-lowering effect. Molecules, 28:2643, Mar 2023. URL: https://doi.org/10.3390/molecules28062643, doi:10.3390/molecules28062643. This article has 15 citations.
(bai2022theroleof pages 3-5): Xiaojing Bai, Meiting Mai, Kai Yao, MengQi Zhang, Yue Huang, Wenbin Zhang, Xiaorou Guo, Yixuan Xu, Ying Zhang, Atikam Qurban, Lijie Duan, Jimei Bu, Jianfeng Zhang, Junfeng Wu, Yong-fei Zhao, Xiangshan Yuan, and Heng-bing Zu. The role of dhcr24 in the pathogenesis of ad: re-cognition of the relationship between cholesterol and ad pathogenesis. Acta Neuropathologica Communications, Mar 2022. URL: https://doi.org/10.1186/s40478-022-01338-3, doi:10.1186/s40478-022-01338-3. This article has 55 citations and is from a peer-reviewed journal.
(cocciadiferro2024exploitinginsilico pages 1-2): Dario Cocciadiferro, Tommaso Mazza, Davide Vecchio, Tommaso Biagini, Francesco Petrizzelli, Emanuele Agolini, Andrea Villani, Daniele Minervino, Diego Martinelli, Cristiano Rizzo, Sara Boenzi, Filippo Maria Panfili, Paola Sabrina Buonuomo, Marina Macchiaiolo, Andrea Bartuli, and Antonio Novelli. Exploiting in silico structural analysis to introduce emerging genotype–phenotype correlations in dhcr24-related sterol biosynthesis disorder: a case study. Frontiers in Genetics, Jan 2024. URL: https://doi.org/10.3389/fgene.2023.1307934, doi:10.3389/fgene.2023.1307934. This article has 7 citations and is from a peer-reviewed journal.
(skubic2024knockoutsofcyp51a1 pages 8-10): Cene Skubic, Hana Trček, Petra Nassib, Tinkara Kreft, Andrew Walakira, Katka Pohar, Sara Petek, Tadeja Režen, Alojz Ihan, and Damjana Rozman. Knockouts of cyp51a1, dhcr24, or sc5d from cholesterol synthesis reveal pathways modulated by sterol intermediates. iScience, 27:110651, Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110651, doi:10.1016/j.isci.2024.110651. This article has 10 citations and is from a peer-reviewed journal.
(peeples2024chemicalinhibitionof pages 17-18): Eric Peeples, Karoly Mirnics, and Zeljka Korade. Chemical inhibition of sterol biosynthesis. Biomolecules, 14:410, Mar 2024. URL: https://doi.org/10.3390/biom14040410, doi:10.3390/biom14040410. This article has 17 citations.
(zhang2023dhcr24reversesalzheimer’s pages 1-2): Wen-bin Zhang, Yue Huang, Xiao-rou Guo, Meng-qi Zhang, Xiang-shan Yuan, and Heng-bing Zu. Dhcr24 reverses alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xfad mice. Acta Neuropathologica Communications, Jun 2023. URL: https://doi.org/10.1186/s40478-023-01593-y, doi:10.1186/s40478-023-01593-y. This article has 38 citations and is from a peer-reviewed journal.
(zhang2023dhcr24reversesalzheimer’s pages 14-15): Wen-bin Zhang, Yue Huang, Xiao-rou Guo, Meng-qi Zhang, Xiang-shan Yuan, and Heng-bing Zu. Dhcr24 reverses alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xfad mice. Acta Neuropathologica Communications, Jun 2023. URL: https://doi.org/10.1186/s40478-023-01593-y, doi:10.1186/s40478-023-01593-y. This article has 38 citations and is from a peer-reviewed journal.
(wang2024cholesterolneutralizedvemurafenib pages 10-13): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.
(wang2024cholesterolneutralizedvemurafenib media 6e0d6af5): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.
(lu2023highfatdiet pages 9-12): Ziyin Lu, Haozhen Wang, Xiujin Zhang, Xiuting Huang, Shan Jiang, Yang Li, Ting Liu, Xiuli Lu, and Bing Gao. High fat diet induces brain injury and neuronal apoptosis via down-regulating 3-β hydroxycholesterol 24 reductase (dhcr24). Cell and Tissue Research, 393:471-487, Jul 2023. URL: https://doi.org/10.1007/s00441-023-03804-3, doi:10.1007/s00441-023-03804-3. This article has 8 citations and is from a peer-reviewed journal.
(fu2024dhcr24intumor pages 2-3): Xin Fu and Zhaosong Wang. Dhcr24 in tumor diagnosis and treatment: a comprehensive review. Technology in Cancer Research & Treatment, Jan 2024. URL: https://doi.org/10.1177/15330338241259780, doi:10.1177/15330338241259780. This article has 17 citations and is from a peer-reviewed journal.
(skubic2024knockoutsofcyp51a1 pages 10-12): Cene Skubic, Hana Trček, Petra Nassib, Tinkara Kreft, Andrew Walakira, Katka Pohar, Sara Petek, Tadeja Režen, Alojz Ihan, and Damjana Rozman. Knockouts of cyp51a1, dhcr24, or sc5d from cholesterol synthesis reveal pathways modulated by sterol intermediates. iScience, 27:110651, Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110651, doi:10.1016/j.isci.2024.110651. This article has 10 citations and is from a peer-reviewed journal.
(peeples2024chemicalinhibitionof pages 6-7): Eric Peeples, Karoly Mirnics, and Zeljka Korade. Chemical inhibition of sterol biosynthesis. Biomolecules, 14:410, Mar 2024. URL: https://doi.org/10.3390/biom14040410, doi:10.3390/biom14040410. This article has 17 citations.
(wang2024cholesterolneutralizedvemurafenib pages 1-2): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.
(wang2024cholesterolneutralizedvemurafenib media ab69483a): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.
id: Q15392
gene_symbol: DHCR24
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: DHCR24 encodes Delta(24)-sterol reductase (also known as seladin-1),
the terminal enzyme in cholesterol biosynthesis that catalyzes the reduction of
the delta-24 double bond of sterol intermediates, primarily converting desmosterol
to cholesterol. The enzyme is FAD-dependent, requires NADPH as a cofactor, and is
localized to the endoplasmic reticulum membrane. DHCR24 also confers neuroprotection
against oxidative stress and amyloid-beta toxicity. Mutations in DHCR24 cause desmosterolosis,
a rare autosomal recessive disorder of cholesterol biosynthesis characterized by
multiple congenital anomalies and elevated desmosterol levels.
existing_annotations:
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: IBA annotation for cytoplasm is incorrect. DHCR24 is an integral ER membrane
protein with its catalytic domain oriented toward the cytoplasm [PMID:11007892,
PMID:22010141]. The cytoplasmic annotation reflects the cytoplasmic orientation
of the catalytic domain rather than true cytoplasmic localization.
action: REMOVE
reason: This annotation incorrectly implies cytoplasmic localization
when the protein is actually an integral ER membrane protein with a cytoplasmic-facing
catalytic domain. The UniProt record and experimental evidence clearly establish
ER membrane as the primary localization [PMID:11007892, PMID:22010141].
supported_by:
- reference_id: PMID:22010141
supporting_text: We showed that full-length DHCR24 is localized to the membrane
of ER, whereas the predicted transmembrane (TM) domain-deleted DHCR24 mutation
is localized to the cytoplasm. The change of DHCR24 localization suggests
that the N-terminal TM domain is essential for the ER membrane targeting of
DHCR24.
- term:
id: GO:0008202
label: steroid metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: IBA annotation for steroid metabolic process is accurate. DHCR24 is a
key enzyme in cholesterol biosynthesis, which is part of steroid metabolism.
The annotation is at an appropriate level of specificity given that cholesterol
is the precursor for all steroid hormones.
action: ACCEPT
reason: DHCR24 clearly participates in steroid metabolism through its essential
role in cholesterol biosynthesis. Cholesterol is both a steroid itself and the
precursor for all steroid hormones. The IBA annotation is well-supported by
experimental evidence [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: We identified the human DHCR24 cDNA, by the similarity between
the encoded protein and a recently characterized plant enzyme—DWF1/DIM, from
Arabidopsis thaliana —catalyzing a different but partially similar reaction
in steroid/sterol biosynthesis in plants. Heterologous expression, in the
yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity
measurements, confirmed that it encodes DHCR24
- term:
id: GO:0000246
label: Delta24(24-1) sterol reductase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: IBA annotation for Delta24(24-1) sterol reductase activity is correct
and represents a core molecular function. This term specifically describes the
enzymatic activity of DHCR24 in reducing the delta-24 double bond in sterols,
which is directly validated by experimental evidence [PMID:11519011].
action: ACCEPT
reason: This is the core molecular function of DHCR24, experimentally validated
through multiple studies. The enzyme specifically catalyzes the reduction of
the delta-24 double bond in sterol intermediates, including desmosterol, lanosterol,
and zymosterol [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
and is increased twofold by the addition of FAD to the assay
- term:
id: GO:0050614
label: Delta24-sterol reductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000003
review:
summary: IEA annotation for Delta24-sterol reductase activity based on EC number
mapping. This is essentially the same function as GO:0000246 but with slightly
different terminology. Both terms correctly describe the core enzymatic function
of DHCR24.
action: ACCEPT
reason: This annotation accurately describes the enzymatic activity of DHCR24.
The term is based on EC:1.3.1.72 mapping which is experimentally validated [PMID:11519011].
This is a duplicate of GO:0000246 with different terminology but both are correct.
supported_by:
- reference_id: PMID:11519011
supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
of sterol intermediates
- term:
id: GO:0000139
label: Golgi membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: IEA annotation for Golgi membrane based on UniProt subcellular location
vocabulary. DHCR24 is detected in Golgi to a lesser extent than ER, where
cholesterol synthesis occurs [PMID:11007892].
action: KEEP_AS_NON_CORE
reason: Golgi localization occurs to a minor extent and is not the primary
functionally relevant site. The ER membrane is the established primary location for DHCR24
function in cholesterol biosynthesis. UniProt notes both localizations but emphasizes
ER [PMID:11007892].
supported_by:
- reference_id: PMID:11007892
supporting_text: subcellular fractionation and enzyme assays... seladin-1 is
predominantly localized within the ER, and to a lesser amount in Golgi complexes
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: IEA annotation for endoplasmic reticulum membrane is accurate and represents
the primary cellular localization. This is the established site where DHCR24
performs its enzymatic function in cholesterol biosynthesis, confirmed by multiple
experimental studies [PMID:11007892, PMID:22010141].
action: ACCEPT
reason: ER membrane is the correct and primary localization for DHCR24. This is
where the enzyme performs its function in cholesterol biosynthesis. Multiple
experimental studies confirm this localization [PMID:11007892, PMID:22010141].
supported_by:
- reference_id: PMID:11007892
supporting_text: seladin-1 is predominantly localized within the ER, and to
a lesser amount in Golgi complexes
- term:
id: GO:0006629
label: lipid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: IEA annotation for lipid metabolic process based on UniProt keyword mapping.
This is accurate but very general. More specific terms like cholesterol biosynthetic
process (GO:0006695) better describe the function.
action: ACCEPT
reason: While accurate, this is a very broad parent term. DHCR24 does participate
in lipid metabolism through its role in cholesterol biosynthesis. However, more
specific child terms provide better functional description.
supported_by:
- reference_id: PMID:11519011
supporting_text: in cholesterol biosynthesis, catalyzes the reduction of the
Δ 24 double bond of sterol intermediates
- term:
id: GO:0006694
label: steroid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: IEA annotation for steroid biosynthetic process is accurate. DHCR24 is
essential for cholesterol biosynthesis, and cholesterol is both a steroid and
the precursor for all steroid hormones.
action: ACCEPT
reason: DHCR24 directly participates in steroid biosynthesis through its essential
role in producing cholesterol, which is a steroid molecule and the precursor
for all steroid hormones [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: desmosterolosis is a cholesterol-biosynthesis disorder caused
by mutations in DHCR24
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: IEA annotation for cholesterol biosynthetic process is accurate and represents
a core function. DHCR24 is the terminal enzyme in cholesterol biosynthesis,
converting desmosterol to cholesterol [PMID:11519011].
action: ACCEPT
reason: This is a core biological process for DHCR24. The enzyme catalyzes the
final step in cholesterol biosynthesis, converting desmosterol to cholesterol.
This is experimentally validated [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
- term:
id: GO:0008202
label: steroid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Duplicate IEA annotation for steroid metabolic process (also annotated
with IBA evidence). The annotation is accurate as DHCR24 participates in cholesterol/steroid
metabolism.
action: ACCEPT
reason: Duplicate but accurate annotation. DHCR24 participates in steroid metabolism
through cholesterol biosynthesis. The IBA version of this annotation was already
accepted.
supported_by:
- reference_id: PMID:11519011
supporting_text: cholesterol-biosynthesis disorder caused by mutations in DHCR24
- term:
id: GO:0008203
label: cholesterol metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: IEA annotation for cholesterol metabolic process is accurate. DHCR24
is directly involved in cholesterol metabolism as the terminal enzyme in cholesterol
biosynthesis.
action: ACCEPT
reason: DHCR24 is a key enzyme in cholesterol metabolism, specifically in the
biosynthetic pathway. The annotation accurately captures this core function
[PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
of sterol intermediates
- term:
id: GO:0016126
label: sterol biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: IEA annotation for sterol biosynthetic process is accurate. DHCR24 is
essential for sterol biosynthesis, specifically in the final step of converting
sterol intermediates to cholesterol.
action: ACCEPT
reason: DHCR24 is a key enzyme in sterol biosynthesis, catalyzing the reduction
of the delta-24 double bond in various sterol intermediates including desmosterol,
lanosterol, and zymosterol [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: catalyzes the reduction of the Δ 24 double bond of sterol intermediates
- term:
id: GO:0016491
label: oxidoreductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: IEA annotation for oxidoreductase activity is accurate but very general.
DHCR24 is indeed an oxidoreductase, specifically a FAD-dependent oxidoreductase
that uses NADPH. More specific terms like GO:0016628 provide better functional
description.
action: ACCEPT
reason: DHCR24 is a FAD-dependent oxidoreductase that catalyzes redox reactions
using NADPH as electron donor. While accurate, more specific child terms better
describe the function [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: member of a recently defined family of flavin adenine dinucleotide
(FAD)-dependent oxidoreductases
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: IEA annotation for FAD binding based on InterPro domain mapping. This
is accurate as DHCR24 contains a FAD-binding domain and FAD enhances its enzymatic
activity [PMID:11519011].
action: ACCEPT
reason: DHCR24 is a FAD-dependent oxidoreductase with a conserved FAD-binding
domain. Addition of FAD increases enzymatic activity twofold, suggesting noncovalent
FAD binding [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
and is increased twofold by the addition of FAD to the assay
- term:
id: GO:0071949
label: FAD binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Duplicate IEA annotation for FAD binding (same as GO:0050660). The annotation
is accurate as DHCR24 is a FAD-dependent enzyme.
action: ACCEPT
reason: Duplicate of GO:0050660 but accurate. DHCR24 requires FAD as a cofactor
for its oxidoreductase activity [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: member of a recently defined family of flavin adenine dinucleotide
(FAD)-dependent oxidoreductases
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:30021884
review:
summary: Generic protein binding annotation from a large-scale crosslinking mass
spectrometry study of intact cell nuclei [PMID:30021884]. The WITH field indicates
interaction with PGRMC1 (O00264). The DHCR24-PGRMC1 interaction was detected
by crosslinking mass spectrometry (both are ER membrane proteins involved
in sterol biology), but the generic protein binding term is uninformative.
action: REMOVE
reason: Protein binding without specificity is uninformative per curation guidelines.
The interaction was detected in a high-throughput crosslinking study and the
functional significance of the DHCR24-PGRMC1 interaction is not well
characterized.
supported_by:
- reference_id: PMID:30021884
supporting_text: Here we use crosslinking mass spectrometry (XL-MS) to chart
the protein-protein interactions in intact human nuclei.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35271311
review:
summary: Generic protein binding annotation from OpenCell high-throughput endogenous
tagging study [PMID:35271311]. The WITH field indicates interaction with PGRMC1
(O00264). While PGRMC1 is a known sterol-binding ER membrane protein, the
generic protein binding term is uninformative per curation guidelines.
action: REMOVE
reason: Non-specific protein binding annotation from high-throughput study lacks
functional context. The curation guidelines explicitly state to avoid this vague
term. A more specific MF term should be used if the interaction is validated.
supported_by:
- reference_id: PMID:35271311
supporting_text: We combined genome engineering, confocal live-cell imaging,
mass spectrometry, and data science to systematically map the localization
and interactions of human proteins.
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-191273
review:
summary: TAS annotation from Reactome for cholesterol biosynthetic process. This
is a core function of DHCR24 as the terminal enzyme in cholesterol biosynthesis.
action: ACCEPT
reason: DHCR24 is the terminal enzyme in cholesterol biosynthesis. This Reactome
annotation accurately captures this core biological process [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: desmosterolosis is a cholesterol-biosynthesis disorder caused
by mutations in DHCR24
- term:
id: GO:0033489
label: cholesterol biosynthetic process via desmosterol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807047
review:
summary: TAS annotation from Reactome for cholesterol biosynthesis via desmosterol.
This is the primary pathway where DHCR24 functions, converting desmosterol to
cholesterol in the Bloch pathway.
action: ACCEPT
reason: This specifically describes the Bloch pathway where DHCR24 catalyzes the
conversion of desmosterol to cholesterol. This is the primary route and core
function of DHCR24 [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
- term:
id: GO:0033490
label: cholesterol biosynthetic process via lathosterol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807062
review:
summary: TAS annotation from Reactome for cholesterol biosynthesis via lathosterol
(Kandutsch-Russell pathway). DHCR24 can act on various sterol intermediates
including those in this alternate pathway.
action: ACCEPT
reason: DHCR24 functions in both the Bloch and Kandutsch-Russell pathways of cholesterol
biosynthesis. It can reduce the delta-24 double bond in various sterol intermediates
[PMID:25637936].
supported_by:
- reference_id: PMID:25637936
supporting_text: DHCR24 is positioned not only at the end of the Bloch pathway
but also at the gateway of the Kandutsch-Russell pathway... able to act on
any of the intermediates in the Bloch pathway to divert them into the Kandutsch-Russell
pathway
- term:
id: GO:0007265
label: Ras protein signal transduction
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for Ras signaling transferred from orthologs. While DHCR24/seladin-1
mediates response to Ras-induced senescence [PMID:15577914], this is a stress
response function rather than core Ras signaling.
action: KEEP_AS_NON_CORE
reason: DHCR24/seladin-1 responds to oncogenic Ras stress but is not a core component
of Ras signaling. It mediates Ras-induced senescence through p53 interactions
[PMID:15577914]. This is a secondary, non-core function.
supported_by:
- reference_id: PMID:15577914
supporting_text: Seladin-1 (also known as Dhcr24) as a key mediator of Ras-induced
senescence. Following oncogenic and oxidative stress, Seladin-1 binds p53
amino terminus
- term:
id: GO:0008104
label: intracellular protein localization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for intracellular protein localization from ortholog transfer.
This is vague and lacks supporting evidence for DHCR24 having a role in localizing
other proteins.
action: REMOVE
reason: No evidence that DHCR24 functions in protein localization. This appears
to be an over-annotation from ortholog transfer without validation. The primary
function is enzymatic in cholesterol biosynthesis.
supported_by:
- reference_id: PMID:11519011
supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
of sterol intermediates
- term:
id: GO:0008285
label: negative regulation of cell population proliferation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for negative regulation of proliferation. DHCR24/seladin-1
does mediate Ras-induced senescence and suppresses transformation [PMID:15577914],
supporting an anti-proliferative role.
action: KEEP_AS_NON_CORE
reason: DHCR24/seladin-1 mediates oncogenic stress-induced senescence and suppresses
cellular transformation [PMID:15577914]. This is a validated but non-core function
distinct from its primary enzymatic role.
supported_by:
- reference_id: PMID:15577914
supporting_text: Ablation of Seladin-1 causes the bypass of Ras-induced senescence
in rodent and human fibroblasts, and allows Ras to transform these cells
- term:
id: GO:0009725
label: response to hormone
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for response to hormone from ortholog transfer. This is
too vague without specifying which hormones. Cholesterol biosynthesis is regulated
by hormones but this annotation lacks specificity.
action: REMOVE
reason: Overly broad annotation without supporting evidence for specific hormone
responses by DHCR24. While cholesterol biosynthesis is hormonally regulated,
this vague annotation provides no functional insight.
supported_by:
- reference_id: PMID:11519011
supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
of sterol intermediates
- term:
id: GO:0009888
label: tissue development
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for tissue development from ortholog transfer. While DHCR24
mutations cause developmental anomalies in desmosterolosis, this is an indirect
effect of cholesterol deficiency.
action: KEEP_AS_NON_CORE
reason: DHCR24 deficiency causes developmental defects in desmosterolosis patients
[PMID:11519011], but this is secondary to cholesterol deficiency rather than
a direct developmental role. Non-core but valid consequence.
supported_by:
- reference_id: PMID:11519011
supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
by multiple congenital anomalies
- term:
id: GO:0016125
label: sterol metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for sterol metabolic process is accurate. DHCR24 is directly
involved in sterol metabolism through its enzymatic activity on various sterol
intermediates.
action: ACCEPT
reason: DHCR24 directly participates in sterol metabolism by catalyzing the reduction
of the delta-24 double bond in multiple sterol intermediates [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: catalyzes the reduction of the Δ 24 double bond of sterol intermediates
- term:
id: GO:0030539
label: male genitalia development
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for male genitalia development from ortholog transfer.
While desmosterolosis can include urogenital anomalies, this is too specific
and indirect.
action: REMOVE
reason: Over-specific developmental annotation. While desmosterolosis includes
congenital anomalies, singling out male genitalia development is not supported
as a specific function of DHCR24. This is an indirect effect of cholesterol
deficiency.
supported_by:
- reference_id: PMID:11519011
supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
by multiple congenital anomalies
- term:
id: GO:0031639
label: plasminogen activation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for plasminogen activation from ortholog transfer. No
evidence supports DHCR24 involvement in plasminogen activation. This is
an erroneous transfer.
action: REMOVE
reason: No evidence linking DHCR24 to plasminogen activation. This is
an incorrect ortholog transfer. DHCR24 functions in cholesterol biosynthesis,
not coagulation/fibrinolysis pathways.
supported_by:
- reference_id: PMID:11519011
supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
of sterol intermediates
- term:
id: GO:0042987
label: amyloid precursor protein catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for APP catabolism from ortholog transfer. While DHCR24/seladin-1
protects against amyloid-beta toxicity [PMID:11007892], it does not directly
catabolize APP.
action: REMOVE
reason: DHCR24/seladin-1 protects against amyloid-beta toxicity but does not catabolize
APP. The protective effect is through reducing oxidative stress and caspase
activation, not APP processing [PMID:11007892].
supported_by:
- reference_id: PMID:11007892
supporting_text: Functional expression of seladin-1 in human neuroglioma H4
cells resulted in the inhibition of caspase 3 activation after either Aβ-mediated
toxicity or oxidative stress and protected the cells from apoptotic cell death
- term:
id: GO:0043588
label: skin development
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for skin development from ortholog transfer. While cholesterol
is important for skin barrier function, this is an indirect effect of DHCR24
enzymatic activity.
action: KEEP_AS_NON_CORE
reason: Cholesterol biosynthesis is important for skin development and barrier
function. DHCR24 deficiency can affect skin, but this is secondary to its enzymatic
role. Non-core but valid indirect function.
supported_by:
- reference_id: PMID:11519011
supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
by multiple congenital anomalies
- term:
id: GO:0061024
label: membrane organization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: IEA annotation for membrane organization from ortholog transfer. While
cholesterol is crucial for membrane structure, DHCR24 does not directly organize
membranes.
action: REMOVE
reason: DHCR24 produces cholesterol which affects membrane properties, but the
enzyme itself does not organize membranes. This is an over-interpretation of
its indirect effects through cholesterol production.
supported_by:
- reference_id: PMID:11519011
supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
of sterol intermediates
- term:
id: GO:0050614
label: Delta24-sterol reductase activity
evidence_type: EXP
original_reference_id: PMID:11519011
review:
summary: Experimental evidence for Delta24-sterol reductase activity from the
key paper identifying DHCR24. This is the core molecular function, directly
demonstrated through heterologous expression and enzyme activity measurements.
action: ACCEPT
reason: Direct experimental validation of DHCR24 enzymatic activity. The study
used heterologous expression in yeast followed by enzyme activity measurements
to confirm Delta24-sterol reductase activity [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Heterologous expression, in the yeast Saccharomyces cerevisiae,
of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that
it encodes DHCR24
- term:
id: GO:0050614
label: Delta24-sterol reductase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9755937
review:
summary: TAS annotation from Reactome for Delta24-sterol reductase activity, specifically
for lanosterol reduction. This is a validated core molecular function of DHCR24.
action: ACCEPT
reason: DHCR24 catalyzes the reduction of the delta-24 double bond in multiple
sterols including lanosterol. This Reactome annotation correctly captures this
enzymatic activity [PMID:11519011].
supported_by:
- reference_id: file:human/DHCR24/DHCR24-uniprot.txt
supporting_text: Reaction=lanosterol + NADPH + H(+) = 24,25-dihydrolanosterol
+ NADP(+)
- term:
id: GO:0000246
label: Delta24(24-1) sterol reductase activity
evidence_type: IMP
original_reference_id: PMID:11519011
review:
summary: IMP evidence for Delta24(24-1) sterol reductase activity from mutant
phenotype analysis. Mutations in DHCR24 cause desmosterolosis with accumulation
of desmosterol, proving this enzymatic function.
action: ACCEPT
reason: Mutations in DHCR24 cause desmosterolosis with elevated desmosterol levels,
directly demonstrating the enzyme's Delta24-sterol reductase activity through
mutant phenotype [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Patients with desmosterolosis have elevated levels of the cholesterol
precursor desmosterol, in plasma, tissue, and cultured cells; this abnormality
suggests a deficiency of the enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: NAS
original_reference_id: PMID:11007892
review:
summary: NAS evidence for ER membrane localization from the seladin-1 paper. Subcellular
fractionation confirmed predominant ER localization. This is the primary and
functionally relevant cellular location.
action: ACCEPT
reason: Experimental subcellular fractionation demonstrated that seladin-1/DHCR24
is predominantly localized to the ER membrane, where it performs its enzymatic
function [PMID:11007892].
supported_by:
- reference_id: PMID:11007892
supporting_text: subcellular fractionation and enzyme assays... seladin-1 is
predominantly localized within the ER, and to a lesser amount in Golgi complexes
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IMP
original_reference_id: PMID:11519011
review:
summary: IMP evidence for cholesterol biosynthetic process from mutant phenotype.
DHCR24 mutations cause desmosterolosis with defective cholesterol biosynthesis,
proving this core function.
action: ACCEPT
reason: Mutations in DHCR24 cause desmosterolosis, a cholesterol biosynthesis
disorder, directly demonstrating the enzyme's essential role in cholesterol
biosynthesis [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Our data demonstrate that desmosterolosis is a cholesterol-biosynthesis
disorder caused by mutations in DHCR24
- term:
id: GO:0033489
label: cholesterol biosynthetic process via desmosterol
evidence_type: IMP
original_reference_id: PMID:11519011
review:
summary: IMP evidence for cholesterol biosynthesis via desmosterol pathway. Patients
with DHCR24 mutations accumulate desmosterol, proving this is the enzyme that
converts desmosterol to cholesterol.
action: ACCEPT
reason: DHCR24 deficiency causes desmosterol accumulation, directly demonstrating
its role in the desmosterol-to-cholesterol conversion in the Bloch pathway [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Patients with desmosterolosis have elevated levels of the cholesterol
precursor desmosterol... Conversion of desmosterol to cholesterol by DHCR24
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25637936
review:
summary: IPI evidence for protein binding with DHCR7. While this specific DHCR7
interaction is functionally important, the generic "protein binding" term should
be avoided per curation guidelines.
action: REMOVE
reason: Generic protein binding annotation should be removed even for specific
interactions. The functionally relevant DHCR7 interaction and its regulatory
effect on enzyme activity is better captured by more specific functional terms.
supported_by:
- reference_id: PMID:25637936
supporting_text: when the DHCR24 gene is knocked down by siRNA, DHCR7 activity
is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity,
but only when a functional form of DHCR24 is used
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-196417
review:
summary: TAS annotation from Reactome for ER membrane localization. This is the
correct primary localization where DHCR24 performs its enzymatic function.
action: ACCEPT
reason: ER membrane is the established localization for DHCR24 where it catalyzes
the conversion of desmosterol to cholesterol [PMID:11007892, PMID:22010141].
supported_by:
- reference_id: PMID:22010141
supporting_text: The membrane topological analysis of 3β-hydroxysteroid-delta24
reductase (DHCR24) on endoplasmic reticulum
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807064
review:
summary: Another TAS annotation from Reactome for ER membrane. This is a duplicate
but correct annotation for the primary cellular localization.
action: ACCEPT
reason: Duplicate but accurate ER membrane localization annotation from Reactome.
Multiple evidence sources confirm this localization [PMID:11007892].
supported_by:
- reference_id: PMID:11007892
supporting_text: seladin-1 is predominantly localized within the ER
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9755937
review:
summary: Another TAS annotation from Reactome for ER membrane. Multiple Reactome
pathways correctly place DHCR24 at the ER membrane.
action: ACCEPT
reason: Another duplicate but accurate ER membrane annotation. The ER is where
DHCR24 performs its enzymatic function in cholesterol biosynthesis [PMID:11007892].
supported_by:
- reference_id: PMID:11007892
supporting_text: seladin-1 is predominantly localized within the ER
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
review:
summary: HDA evidence for membrane localization from NK cell proteomics study.
This is very general compared to the specific ER membrane localization established
by other studies.
action: ACCEPT
reason: While less specific than ER membrane annotations, this high-throughput
data confirms DHCR24 is membrane-associated, consistent with its ER membrane
localization [PMID:19946888].
supported_by:
- reference_id: PMID:19946888
supporting_text: Defining the membrane proteome of NK cells
- term:
id: GO:0016628
label: oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP
as acceptor
evidence_type: IDA
original_reference_id: PMID:11519011
review:
summary: IDA evidence for specific oxidoreductase activity. This accurately describes
DHCR24 mechanism - it reduces C-C double bonds (delta-24) using NADPH as electron
donor.
action: ACCEPT
reason: Direct experimental demonstration that DHCR24 is an oxidoreductase acting
on CH-CH groups (the delta-24 double bond) with NADPH as acceptor. This is more
specific than general oxidoreductase activity [PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for cholesterol biosynthetic process based on sequence
similarity. This is a duplicate annotation but correctly identifies a core function.
action: ACCEPT
reason: Sequence similarity-based annotation that correctly identifies DHCR24
role in cholesterol biosynthesis. This is validated by experimental evidence
[PMID:11519011].
supported_by:
- reference_id: PMID:11519011
supporting_text: desmosterolosis is a cholesterol-biosynthesis disorder caused
by mutations in DHCR24
- term:
id: GO:0019899
label: enzyme binding
evidence_type: IPI
original_reference_id: PMID:15577914
review:
summary: IPI evidence for enzyme binding from the seladin-1 stress response paper.
DHCR24/seladin-1 binds to Mdm2 (an E3 ubiquitin ligase) to regulate p53. This
is a non-core stress response function.
action: KEEP_AS_NON_CORE
reason: DHCR24/seladin-1 binds the E3 ubiquitin ligase Mdm2 during stress response,
affecting p53 regulation. This is a validated but non-core function distinct
from its primary enzymatic role [PMID:15577914].
supported_by:
- reference_id: PMID:15577914
supporting_text: Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin
ligase Mdm2 from p53... Additionally, Seladin-1 associates with Mdm2 independently
of p53
- term:
id: GO:0043588
label: skin development
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for skin development based on sequence similarity. While
cholesterol is important for skin, this is an indirect effect of DHCR24 enzymatic
function.
action: KEEP_AS_NON_CORE
reason: Cholesterol biosynthesis impacts skin development and barrier function.
DHCR24 deficiency can cause skin abnormalities, but this is secondary to its
enzymatic role. Non-core indirect function.
supported_by:
- reference_id: PMID:11519011
supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
by multiple congenital anomalies
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:15577914
review:
summary: IDA evidence for nuclear localization from stress response study.
DHCR24/seladin-1 translocates to the nucleus during oncogenic and oxidative
stress [PMID:15577914], though the primary functional localization is ER membrane.
action: KEEP_AS_NON_CORE
reason: DHCR24/seladin-1 can localize to nucleus during stress response to interact
with p53/Mdm2, but this is not the primary localization. Main function occurs
at ER membrane [PMID:15577914, PMID:11007892].
supported_by:
- reference_id: PMID:15577914
supporting_text: Following oncogenic and oxidative stress, Seladin-1 binds p53
amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IDA
original_reference_id: PMID:11007892
review:
summary: IDA evidence for ER localization from the seladin-1 paper. This is the
correct primary localization, though ER membrane (GO:0005789) is more specific.
action: ACCEPT
reason: Direct experimental evidence for ER localization through subcellular fractionation.
The more specific ER membrane term is also annotated [PMID:11007892].
supported_by:
- reference_id: PMID:11007892
supporting_text: subcellular fractionation and enzyme assays... seladin-1 is
predominantly localized within the ER
- term:
id: GO:0009888
label: tissue development
evidence_type: IMP
original_reference_id: PMID:12457401
review:
summary: IMP evidence for tissue development from a desmosterolosis case report
showing developmental delay and anomalies. This is an indirect effect of cholesterol
deficiency rather than a direct developmental role.
action: KEEP_AS_NON_CORE
reason: DHCR24 deficiency causes developmental anomalies in desmosterolosis due
to cholesterol deficiency. This is an indirect consequence rather than a direct
developmental function [PMID:12457401].
supported_by:
- reference_id: PMID:12457401
supporting_text: Desmosterolosis presenting with multiple congenital anomalies
and profound developmental delay
- term:
id: GO:0042605
label: peptide antigen binding
evidence_type: IPI
original_reference_id: PMID:15577914
review:
summary: IPI evidence for peptide antigen binding from the seladin-1 stress response
study [PMID:15577914]. The WITH field shows UniProtKB:P04637 (p53), indicating
the annotation was made based on seladin-1 binding the p53 N-terminus.
However, this interaction is protein-protein binding to p53 during stress
response, not peptide antigen binding in an immunological sense. The GO term
peptide antigen binding (GO:0042605) refers to binding of antigenic peptides
for immune presentation, which does not describe the DHCR24-p53 interaction.
action: REMOVE
reason: This is a misannotation. PMID:15577914 describes DHCR24/seladin-1
binding to the p53 amino terminus during oncogenic and oxidative stress, displacing
Mdm2. This is a protein-protein interaction, not peptide antigen binding in the
immunological sense. No MHC or antigen presentation function is described.
supported_by:
- reference_id: PMID:15577914
supporting_text: Following oncogenic and oxidative stress, Seladin-1 binds p53
amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53, thus
resulting in p53 accumulation.
core_functions:
- description: Catalyzes the reduction of the delta-24 double bond in sterol intermediates
using NADPH and FAD as cofactors, converting desmosterol to cholesterol as the
terminal step of cholesterol biosynthesis
molecular_function:
id: GO:0050614
label: Delta24-sterol reductase activity
directly_involved_in:
- id: GO:0006695
label: cholesterol biosynthetic process
- id: GO:0033489
label: cholesterol biosynthetic process via desmosterol
- id: GO:0033490
label: cholesterol biosynthetic process via lathosterol
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
substrates:
- id: CHEBI:17737
label: desmosterol
- id: CHEBI:16521
label: lanosterol
- id: CHEBI:18252
label: zymosterol
- description: Positively regulates DHCR7 oxidoreductase activity through direct protein
interaction, enhancing 7-dehydrocholesterol reductase function in cholesterol
biosynthesis
supported_by:
- reference_id: PMID:25637936
supporting_text: when the DHCR24 gene is knocked down by siRNA, DHCR7 activity
is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity
molecular_function:
id: GO:0050614
label: Delta24-sterol reductase activity
directly_involved_in:
- id: GO:0006695
label: cholesterol biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms.
findings: []
- id: GO_REF:0000003
title: Gene Ontology annotation based on Enzyme Commission mapping
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt.
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara.
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
findings: []
- id: PMID:11007892
title: The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's
disease-associated neurodegeneration and oxidative stress.
findings: []
- id: PMID:11519011
title: Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis,
an autosomal recessive disorder of cholesterol biosynthesis.
findings: []
- id: PMID:12457401
title: Desmosterolosis presenting with multiple congenital anomalies and profound
developmental delay.
findings: []
- id: PMID:15577914
title: Regulation of cellular response to oncogenic and oxidative stress by Seladin-1.
findings: []
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings: []
- id: PMID:25637936
title: The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact
physically and functionally.
findings: []
- id: PMID:30021884
title: Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry
in Intact Cell Nuclei.
findings: []
- id: PMID:35271311
title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
findings: []
- id: Reactome:R-HSA-191273
title: Cholesterol biosynthesis
findings: []
- id: Reactome:R-HSA-196417
title: Reduction of desmosterol to cholesterol
findings: []
- id: Reactome:R-HSA-6807047
title: Cholesterol biosynthesis via desmosterol
findings: []
- id: Reactome:R-HSA-6807062
title: Cholesterol biosynthesis via lathosterol
findings: []
- id: Reactome:R-HSA-6807064
title: DHCR24 reduces ZYMOL to ZYMSTNL
findings: []
- id: Reactome:R-HSA-9755937
title: DHCR24 reduces LAN to 24,25-dhLAN
findings: []
suggested_questions:
- question: How does DHCR24 coordinate cholesterol biosynthesis with membrane homeostasis
and cellular sterol requirements?
- question: What are the regulatory mechanisms that control DHCR24 expression and
activity in response to sterol levels?
- question: How do mutations in DHCR24 lead to desmosterolosis and what
are the developmental consequences of altered sterol metabolism?
- question: What determines the subcellular localization of DHCR24 and how does this
affect its function in sterol metabolism?
suggested_experiments:
- description: Lipidomics analysis to characterize the complete sterol profile in
DHCR24-deficient cells and tissues
- description: Live-cell imaging using fluorescent sterol analogs to track cholesterol
metabolism and membrane distribution in real-time
- description: Cryo-EM structure determination of DHCR24 to understand the molecular
basis of sterol reduction and enzyme specificity
- description: Developmental analysis of DHCR24 mutant model organisms to study the
role of cholesterol in embryogenesis and organogenesis
status: COMPLETE
📊 View Pathway Visualization Interactive pathway diagram with detailed annotations